BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 17176913)

  • 1. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
    Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B
    Clin Nephrol; 2006 Dec; 66(6):418-25. PubMed ID: 17176913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
    Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
    J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
    Franke S; Müller A; Sommer M; Busch M; Kientsch-Engel R; Stein G
    Clin Nephrol; 2003 Feb; 59(2):88-97. PubMed ID: 12608551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum pentosidine with arterial stiffness in hemodialysis patients.
    Zhou Y; Yu Z; Jia H; Sun F; Ma L; Guo R; Peng L; Cui T
    Artif Organs; 2010 Mar; 34(3):193-9. PubMed ID: 20447043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites.
    Klemm A; Franke C; Busch M; Müller A; Franke S; Lang D; Passlick-Deetjen J; Stein G
    Clin Nephrol; 2004 Mar; 61(3):191-7. PubMed ID: 15077870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).
    Held C; Sumner G; Sheridan P; McQueen M; Smith S; Dagenais G; Yusuf S; Lonn E
    Vasc Med; 2008 Nov; 13(4):245-53. PubMed ID: 18940900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients.
    Zoccali C; Mallamaci F; Asahia K; Benedetto FA; Tripepi G; Tripepi R; Nicocia G; Buemi M; Miyata T
    J Nephrol; 2001; 14(4):293-8. PubMed ID: 11506253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease].
    Yang XB; Hou FF; Wu Q; Zhou H; Liu ZR; Yang Y; Zhang X
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):342-6. PubMed ID: 16009002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of homocysteine on carotid intima-media thickness after renal transplantation.
    Suwelack B; Gerhardt U; Witta J; Rahn KH; Hohage H
    Clin Transplant; 2000 Dec; 14(6):555-60. PubMed ID: 11127308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
    Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
    Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
    Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U
    Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity.
    Stenvinkel P; Heimbürger O; Jogestrand T
    Am J Kidney Dis; 2002 Feb; 39(2):274-82. PubMed ID: 11840367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
    Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasma pentosidine level is accompanied with cardiovascular events in hemodialysis patients.
    Furuya R; Kumagai H; Miyata T; Fukasawa H; Isobe S; Kinoshita N; Hishida A
    Clin Exp Nephrol; 2012 Jun; 16(3):421-6. PubMed ID: 22160670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress".
    Izuhara Y; Miyata T; Saito K; Ishikawa N; Kakuta T; Nangaku M; Yoshida H; Saito A; Kurokawa K; van Ypersele de Strihou C
    Am J Kidney Dis; 2004 Jun; 43(6):1024-9. PubMed ID: 15168382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients.
    Stein G; Franke S; Mahiout A; Schneider S; Sperschneider H; Borst S; Vienken J
    Nephrol Dial Transplant; 2001 May; 16(5):999-1008. PubMed ID: 11328907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].
    Yu YM; Hou FF; Zhang X; Zhou H; Liu ZQ
    Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):292-5. PubMed ID: 15130417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
    Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
    J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.
    Suliman ME; Qureshi AR; Bárány P; Stenvinkel P; Filho JC; Anderstam B; Heimbürger O; Lindholm B; Bergström J
    Kidney Int; 2000 Apr; 57(4):1727-35. PubMed ID: 10760109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of hyperhomocysteinemia on atherosclerosis in patients with chronic renal failure].
    Yu Y; Hou F; Zhou H; Yang Y; Zhang X; Yang L; Hu M
    Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):517-21. PubMed ID: 12421497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.